Loading viewer...
earnings
Format: PDF earnings
Q1 2023 earnings presentation with sales of $266.0M representing 45.5% organic year-over-year growth. Gross profit margin of 29.0% increased 380 basis points year-over-year, EBITDA reached $54.6M with a 20.5% margin, and diluted EPS doubled to $0.67. Backlog grew 30.0% year-over-year to $599.9M.
investor_presentation
18 Pages
earnings
20 Pages
Universal Robina Corporation
The Hartford Financial Services Q2 2016 Earnings Presentation
earningsearnings
23 Pages
The Hartford Financial Services Group, Inc.
Relmada Therapeutics 2022 Earnings Call REL-1017 Results
earningsearnings
13 Pages
Relmada Therapeutics, Inc.
Finning International Q3 2016 Earnings Release
earningsearnings
54 Pages
Finning International